atenolol has been researched along with Angiogenesis, Pathologic in 1 studies
Atenolol: A cardioselective beta-1 adrenergic blocker possessing properties and potency similar to PROPRANOLOL, but without a negative inotropic effect.
atenolol : An ethanolamine compound having a (4-carbamoylmethylphenoxy)methyl group at the 1-position and an N-isopropyl substituent.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Propranolol and atenolol, current therapies for problematic infantile hemangioma (IH), are composed of R(+) and S(-) enantiomers: the R(+) enantiomer is largely devoid of beta blocker activity." | 8.12 | Non-beta blocker enantiomers of propranolol and atenolol inhibit vasculogenesis in infantile hemangioma. ( Bischoff, J; Fontaine, F; Francois, M; Graus, MS; Huang, L; Karnezis, T; McCann, A; Meunier, F; Mulliken, JB; Seebauer, CT; Staffa, SJ; Wylie-Sears, J; Zurakowski, D, 2022) |
| "Propranolol and atenolol, current therapies for problematic infantile hemangioma (IH), are composed of R(+) and S(-) enantiomers: the R(+) enantiomer is largely devoid of beta blocker activity." | 4.12 | Non-beta blocker enantiomers of propranolol and atenolol inhibit vasculogenesis in infantile hemangioma. ( Bischoff, J; Fontaine, F; Francois, M; Graus, MS; Huang, L; Karnezis, T; McCann, A; Meunier, F; Mulliken, JB; Seebauer, CT; Staffa, SJ; Wylie-Sears, J; Zurakowski, D, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Seebauer, CT | 1 |
| Graus, MS | 1 |
| Huang, L | 1 |
| McCann, A | 1 |
| Wylie-Sears, J | 1 |
| Fontaine, F | 1 |
| Karnezis, T | 1 |
| Zurakowski, D | 1 |
| Staffa, SJ | 1 |
| Meunier, F | 1 |
| Mulliken, JB | 1 |
| Bischoff, J | 1 |
| Francois, M | 1 |
1 other study available for atenolol and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Non-beta blocker enantiomers of propranolol and atenolol inhibit vasculogenesis in infantile hemangioma.
Topics: Animals; Atenolol; Hemangioma; Humans; Mice; Neoplastic Stem Cells; Neovascularization, Pathologic; | 2022 |